Day: September 20, 2022

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Non-squamous Non-Small Cell Lung Cancer

–6th approved indication of toripalimab in China, bringing more treatment options to patients with advanced NSCLC SHANGHAI, China, Sept. 20, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company

Movellus Secures $23M in Series B Funding to Accelerate Growth

MESH leads the round, with SK hynix joining as a strategic investor. SAN JOSE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Movellus, today announced the closing of a $23M Series B to accelerate the company’s growth. The funding will be